Dorian LPG Beats Fiscal Q2 2027 Estimates as Revenue Rises 83% to $221.3M
Revenue of $221.3M vs. $194.9M expected and adjusted EPS of $3.46 vs. $2.85; revenue up 83% from a year earlier.
Dorian LPG (LPG) beat estimates for the fiscal second quarter of 2027 on both revenue and adjusted EPS. Revenue was $221.3 million, up 83% from a year earlier, above the $194.9 million estimate, and adjusted EPS was $3.46, up 164% from a year earlier, above the $2.85 estimate.
Fiscal Q2 2027 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $2.85 | $3.46 | Beat by 21% |
| Revenue | $194.9M | $221.3M | Beat by 14% |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▲ 164% | ▲ 37% |
| Revenue | ▲ 83% | ▲ 18% |
By our calculation, revenue was $26.4 million above the estimate and adjusted EPS was $0.61 above it. The QoQ column compares with the previous quarter's revenue of $187.9 million and adjusted EPS of $2.52. The YoY column compares with $120.6 million and $1.31 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 3 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $120.6 million, $120.0 million, $153.3 million, $187.9 million and $221.3 million.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $3.24 and revenue of $205.8 million next quarter, based on 3 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 83% increase to $221.3 million.
- Estimate record. Whether Dorian LPG returns to beating EPS estimates, which it did in 3 of its last 8 reports.
- Related coverage. See our reports on Oscar Health, Perimeter Solutions, Arhaus and Ecovyst.
Sources: Results are from Dorian LPG's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Dorian LPG's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
Oscar Health Beats Q3 2026 Estimates as Revenue Rises 72% to $5.14B
EarningsPerimeter Solutions Q3 2026 Revenue Tops Estimates at $389.9M, but EPS Misses at $0.85
EarningsArhaus Misses Q3 2026 Estimates as Revenue Rises 6.8% to $368.1M
EarningsEcovyst Beats Q3 2026 Estimates as Revenue Rises 51% to $308.6M
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.
